In-hospital Stellate Ganglion Block for Arrhythmic Storm

Recruiting Observational Study
Arrhythmic Storm Electrical Storm Ventricular Fibrillation Ventricular Tachycardia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Arrhythmic storm is a real emergency and its treatment could be challenging. Antiarrhythmic drugs are few and often ineffective. Neuromodulation has been grown in evidences but no large multicentric studies are present in literature about safety and effectiveness of Percutaneous Stellate Ganglion Block (PSGB). Patients with an electrical storm refractory to at least one antiarrhythmic drug will re…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * age ≥ 18 years, * presence of arrhythmic storm defined as more than three sustained ventricular arrhythmias in 24 hours refractory to the standard medical treatment. Exclusion Criteria: * A previous history of cardiac sympathicectomy * Having a neck judged unsuitable for the…
Contacts

Simone Savastano, MD

+39 0382501590

s.savastano@smatteo.pv.it

CONTACT

Alessia Currao, PharmD (CRC)

+39 0382501590

a.currao@smatteo.pv.it

CONTACT